OKYO Pharma (OKYO) Share-based Compensation (2024 - 2026)

OKYO Pharma's (OKYO) quarterly Share-based Compensation came in at $870271.0 in Q1 2026, up 363.97% quarter-over-quarter from $187569.0 in Q4 2025.

Analysis

OKYO Pharma (OKYO) Share-based Compensation (2024 - 2026) Analysis & Trends

OKYO Pharma (OKYO) has reported Share-based Compensation for 3 consecutive years, with $870271.0 the latest figure, recorded in Q1 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Share-based Compensation (Qtr)
1	Amgen	207.59 Bn	193.60 Bn	7.24 Bn	247.00 Mn
2	Gilead Sciences	178.73 Bn	175.55 Bn	6.22 Bn	231.00 Mn
3	Vertex Pharmaceuticals	131.17 Bn	123.32 Bn	2.84 Bn	108.10 Mn
4	Regeneron Pharmaceuticals	81.73 Bn	73.73 Bn	3.93 Bn	243.00 Mn
5	Argenx Se	61.01 Bn	55.82 Bn	1.37 Bn	-
6	Moderna	53.40 Bn	48.27 Bn	52.00 Mn	120.00 Mn
7	Alnylam Pharmaceuticals	33.49 Bn	30.18 Bn	992.69 Mn	86.63 Mn
8	Biogen	31.64 Bn	30.35 Bn	1.96 Bn	77.40 Mn
9	Roivant Sciences	29.66 Bn	29.66 Bn	1.16 Mn	83.34 Mn
10	OKYO Pharma	968.85 Mn	968.85 Mn	-	870,271.00

Historic Data

Download Data